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While both domains are thought to contribute to my-
elin-derived inhibition of neurite growth, Nogo66 specifi-
cally inhibits neurite growth, while the Amino-Nogo frag-Growth inhibition in the central nervous system (CNS)
ment inhibits spreading and migration of non-neuronalis a major barrier to axon regeneration. Recent find-
cells, as well as blocking neurite growth (Fournier et al.,ings indicate that three distinct myelin proteins, my-
2001). The findings that the amino-terminal fragmentelin-associated glycoprotein (MAG), Nogo, and oligo-
possesses inhibitory activity is somewhat perplexing,dendrocyte-myelin glycoprotein (OMgp), inhibit axon
given that structural studies suggest Amino-Nogo is lo-growth by binding a common receptor, the Nogo66
cated on the cytoplasmic side of the membrane. Al-receptor (NgR), and likely converge on a common sig-
though this apparent paradox remains to be resolved,naling cascade.
possibilities include potential conformational changes
in Nogo that might expose the amino-terminal domainIt is now well established that axons of the adult CNS
or potentially that injury in the CNS might result in aare capable of only a limited amount of regrowth after
disruption of myelin such that both domains are ex-injury, and that an unfavorable growth environment
posed. The Strittmatter group followed up on the initialplays a major role in this lack of regeneration. Much of
cloning of Nogo to identify the receptor for the Nogo66the axon growth inhibitory activity in the CNS is associ-
domain, using an expression cloning strategy to isolateated with myelin, and a number of individual proteins
binding proteins. A single receptor, NgR, was identifiedthat inhibit axon growth have been identified. To date,
and found to encode a protein which is associated withthree inhibitory components of myelin have been identi-
the cell membrane by a glycosylphosphatidylinositolfied: myelin-associated glycoprotein (MAG), Nogo, and,
(GPI) linkage (Fournier et al., 2001). Mutated forms ofmost recently, oligodendrocyte-myelin glycoprotein
the receptor eliminated growth inhibition by Nogo66,(OMgp) (Kottis et al., 2002; Wang et al., 2002). Although
supporting its importance as a receptor for Nogo. Struc-distinct in molecular structure, these proteins share a
ture-function analyses suggested that that a leucine-number of common attributes, including their expres-
rich repeat domain is important for Nogo binding. NgRsion and localization in the myelin membrane directly
is highly expressed in brain, and in situ hybridizationadjacent to the axon.
experiments show that NgR is predominantly expressedMAG was identified as the first myelin-derived growth
by neurons (Fournier et al., 2001).inhibitory protein by two distinct experimental strate-
OMgp is the most recently identified of the inhibitorygies. MAG inhibitory activity was detected in myelin after
components of myelin, and was identified independentlyextraction with octylglucoside, fractionation by ion ex-
by two groups. In the initial purification procedure whichchange chromatography, and screening for inhibitory
led to identification of MAG, it was noted that there were
activity (McKerracher et al., 1994), and by a different
two major peaks of inhibitory activity, with MAG present
approach, the Filbin group showed that CHO cells trans-
in the first peak (McKerracher et al., 1994). The Braun
fected with MAG inhibited neurite growth (Mukhopad- group further separated inhibitory proteins in the second
hyay et al., 1994). Although the identification of MAG as peak by PNA-agarose chromatography and identified
a growth inhibitory protein was at first controversial, it OMgp as a potent inhibitor, first naming it Arretin based
is now well established that MAG can function as an on its growth inhibitory properties (Kottis et al., 2002).
inhibitor of neurite growth. Further, it has also been Coming from another angle, the He group identified
shown that MAG is bifunctional; in addition to inhibiting OMgp by testing whether any GPI-anchored myelin pro-
regrowth of adult axons, MAG can stimulate axon re- teins could act as regeneration inhibitors (Wang et al.,
growth from young neurons, and changes in the endoge- 2002a). OMgp was found to be highly enriched in Phos-
nous levels of cAMP may account for these develop- pholipase C-released fractions of myelin and shown to
mental changes in activity. have potent growth cone collapsing and neurite out-
Nogo was reported independently by three groups growth inhibitory activities. The inhibitory activity of
as the long sought after high molecular weight myelin OMgp in vitro appears to be as potent as that of MAG
inhibitor first characterized by the Schwab group (re- and Nogo, and all three proteins have a similar distribu-
viewed in Brittis and Flanagan, 2001). Somewhat sur- tion in the myelin sheath, suggesting that all likely con-
prisingly, Nogo was found to have three different splice tribute to growth inhibition in the adult CNS.
variants: NogoA, NogoB, and NogoC, the latter two of MAG, Nogo, and OMgp Share a Common
which are widely expressed outside the CNS. Only Receptor that Mediates Growth Inhibition
NogoA possesses a unique N-terminal region not shared While recent years have witnessed a spurt in information
about the molecular components of myelin and their
activities, still relatively little is known about how they1Correspondence: mckerral@patho.umontreal.ca
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mediate their inhibitory effects on growing axons. As for shown that Rho is activated in contact with myelin (Win-
any extracellular molecule, understanding the mecha- ton et al., 2002). It has not yet been tested whether Nogo
nisms by which a cell, or in this case, an axon, reads or OMgp ligands acting via NgR can also activate Rho.
this signal requires knowledge of the signal transduction The first indication that Rho family GTPases might
machinery involved. In this respect, identification of NgR play a key role in growth inhibition came from studies of
as the receptor for Nogo represented a critical contribu- lysophophatidic acid (LPA) and neurite retraction. LPA is
tion, it was thought, at least for understanding the mech- known to activate Rho, and the ability of LPA to cause
anisms underlying the effects of Nogo and its particular neurite retraction suggested that Rho might also be in-
contribution to the inhibitory activities of myelin. The volved in growth cone collapse. Lehmann et al. (Leh-
surprise came when it was shown that in addition to mann et al., 1999) showed that cells transfected with
binding Nogo66, the NgR could also bind and mediate dominant-negative Rho could grow neurites on myelin
the inhibitory activities of OMgp (Wang et al., 2002a) substrates, and that treatment with C3 transferase, a
and MAG (Domeniconi et al., 2002; Liu et al., 2002). bacterial endotoxin that inactivates Rho, to inactivate
These studies bring these various molecules to an inter- Rho could also allow neurite growth on inhibitory sub-
section, at the level of the NogoR, and suggest that strates. Similarly, it has now been shown that treatment
these seemingly distinct proteins might have more in of neurons with C3 transferase allows neurite growth in
common than initially anticipated. the presence of chemorelpulsive guidance factors, and
Wang et al. identified the NgR as an OMgp binding moreover, inactivation of Rho with cell-permeable C3
protein via an expression cloning strategy and con-
analogs reverses Rho activation concomitantly with
firmed a functional role for the NgR in growth inhibition
their ability to promote growth on myelin substrates.by OMgp by showing that NgR transfected into neurons
More recently, a Rho kinase inhibitor called Y-27632that would normally not be inhibited by OMgp can make
has been used to probe the role of Rho in growth inhibi-these neurons sensitive to OMgp (Wang et al., 2002a).
tory signaling. Treating neurons with C3 transferase orFollowing closely on the heals of this report, two addi-
with Y-27632 have similar effects—both compoundstional studies showed that in addition to binding Nogo66
promote growth on inhibitory substrates. Moreover,and OMgp, the NgR also binds MAG (Liu et al., 2002;
both compounds override growth inhibition not only byDomeniconi et al., 2002). The Strittmatter group used
myelin, but also by the chondroitin sulfate proteoglycansan alkaline phosphatase-NgR fusion protein to attempt
(Dergham et al., 2002), a family of growth inhibitory pro-to identify NgR co-receptors by expression cloning and,
teins concentrated at regions of the glial scar. A numberin the process, identified MAG (Liu et al., 2002). Indepen-
of laboratories have shown that treatment of neuronsdently, the Filbin group honed in on the NgR receptor
with Y-27632 stimulates neurite growth. More speci-as candidate for MAG binding based on a similarity in
fically, growth cone collapse by chemorepulsive fac-molecular weight to candidates revealed in a previous
tors important in development can be blocked by treat-characterization of MAG binding proteins. Both studies
ment with Y-27632. Therefore, Rho may be a convergentshow that NgR signals growth inhibition by MAG, and
point for signaling by different inhibitory receptors, notthat NgR is a required component of MAG inhibitory
just NgR.signaling.
Therefore, NgR mediates growth inhibition by MAG, Signal Transduction by NgR and p75NTR
Nogo, and OMgp, three structurally different proteins. As the NgR is GPI linked to the cell surface and does
Even more surprising is that all three myelin-derived not have an intracellular signaling domain, it has been
growth inhibitory proteins bind NgR with high affinity of assumed that it must function as a part of a signaling
approximately 5 nM (OMgp, 5 nM [Wang et al., 2002a]; complex and that an accessory co-receptor functions
Nogo66, 7 nM M [Fournier et al., 2001]; MAG, 8 nM M to transduce the signals intracelluarly. So what is the
[Domeniconi et al., 2002]). Also, all three proteins are identity of the NgR’s signaling partner? In a very recent
inhibitory in either substrate bound or soluble form, and study, Wang and colleagues provide strong evidence
dominant-negative NgR removes sensitivity to all three to suggest that a familiar player, p75 NTR, the transmem-
growth inhibitory proteins. The challenge now is to eluci- brane protein previously shown to be a receptor for the
date the signaling mechanisms. neurotrophin family of growth factors, acts as a NgR
Rho GTPase and Growth Inhibition coreceptor (Wang et al, 2002b). In a previous study,
NgR is GPI-linked to the cell surface and does not have
Yamashita and colleagues had suggested that p75NTR
an intracellular signaling domain, so it is assumed that
plays a role in signaling in response to MAG. Theyit must function as a part of a signaling complex. One
showed that neurons isolated from p75NTR null mutantpotential clue to understanding the signal transduction
mice were not inhibited by MAG and that p75NTR expres-mechanisms involved is the demonstration that the
sion colocalized with sites of MAG binding, suggestingsmall GTPase Rho is a key intracellular effector for
that p75NTR clusters with MAG receptors (Yamashita etgrowth inhibitory signaling by myelin. Rho GTPases are
al., 2002). One possibility to explain these results mighta family of highly related proteins that are best charac-
be that p75NTR is a receptor for MAG, but evidence forterized for their effects on the actin cytoskeleton. The
direct binding between MAG and the p75NTR was notmajor members of the Rho family include Rho, Rac, and
found. Following up on these initial observations, WangCdc42. Several isoforms of Rho exist, and in neurons
et al. reasoned that p75 might form part of a receptorRhoA is expressed at higher levels than RhoB and RhoC
complex with the NgR. Indeed, consistent with this(Lehmann et al., 1999). In neurons, myelin and MAG
model, they showed that the NgR binds to the extracellu-inhibit growth by Rho-dependent mechanisms (Leh-
mann et al., 1999), and more specifically, it has been lar domain of p75NTR and that disrupting the interaction
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p75NTR, as detected by immunoprecipitation, suggesting
that gangliosides participate in the MAG receptor-sig-
naling complex (Yamashita et al., 2002). Together with
the new data on NgR, these data suggest a model
whereby ganglioside clustering in membrane rafts might
help promote the formation of NgR receptor complexes
with p75NTR upon MAG binding to NgR (Figure 1).
The evidence in support of an involvement of ganglio-
sides and Rho in inhibitory signaling complexes is
strengthened by studies in which the inhibition of neurite
growth by anti-GT1b antibodies was reversed by treat-
ment with Y27632, the inhibitor to Rho kinase (Vinson
et al., 2001). While NgR is the binding receptor for MAG,
Nogo, and OMgp, at least in the case of MAG signaling,
gangliosides may act to modulate the formation of inhib-
itory signaling complexes in response to ligand binding.
It has not been investigated if gangliosides might also
modulate growth inhibition by OMgp and Nogo. Al-
Figure 1. Schematic Diagram Showing Signaling by Myelin-Derived though as yet untested, it is tempting to speculate that
Growth Inhibitory Proteins the role of gangliosides may be to help cluster and stabi-
MAG, Nogo66, and OMpg all bind with high affinity to the Nogo lize receptor complexes once the ligand binds to NgR
receptor (NgR), likely located in membrane rafts. The NgR interacts (Figure 1). This would be consistent with sustained acti-
with the extracellular domain of p75NTR and in vitro, this interaction
vation of Rho in response to inhibitory signaling (Wintonis required for NgR-mediated responsiveness to MAG, Nogo66, and
et al., 2002).Omgp. We suggest that binding of inhibitory ligands causes cluster-
In particular, given the involvement of p75NTR, it seemsing of gangliosides (GT1b) in membrane rafts and that the p75NTR
also likely forms part of the receptor complex in the membrane rafts. reasonable to wonder about the role of neurotrophin
Rho is activated by growth inhibitory proteins as well as by p75NTR signaling in growth inhibition. Although neurotrophins
and activation of Rho results in growth inhibition, suggesting a po- typically promote neurite growth and survival, they ap-
tential role for Rho activation downstream of the NgR signaling
pear to be relatively ineffective in overcoming growthcomplex.
inhibition (Cai et al., 1999). An interesting exception to
this is that neurotrophins can override growth inhibition
if neurons are exposed to the neurotrophin before plat-between NgR and p75NTR, by either NgR dominant-nega-
ing on growth inhibitory substrates (Cai et al., 1999).tive mutation or in a p75NTR null mutant mouse, makes
These findings are consistent with the observations thatneurons unresponsive to myelin.
in the presence of neurotrophin binding, p75NTR inacti-These findings help explain why growth inhibition by
vates Rho (Yamashita et al., 1999) and perhaps suggest
MAG activates Rho in a p75NTR-dependent manner, since
that once Rho is activated, neurotrophin signaling is
p75NTR has been shown to interact with RhoA. Together
not sufficient to reverse Rho activation. Other cellular
with the findings that NgR binds p75NTR and that NgR
signaling pathways, such as integrin-based signaling,
binds MAG, Nogo, and OMgp, this suggests a model are also well known to reverse Rho activation. Moreover,
whereby myelin inhibition of neurite ougrowth results in laminin, which binds integrins, is known to reverse my-
activation of the receptor signaling complex consisting elin-derived growth inhibition. This suggests that extra-
of the NgR, which binds to inhibitory components in cellular matrix interactions may play a role in modulating
myelin, and the signaling receptor p75NTR. growth inhibition as well.
How might such an inhibitory signaling complex func- The Role of cAMP in a Common Signaling
tion in the context of the cell? There is evidence to Pathway in Growth Inhibition
suggest that growth inhibitory signaling complexes may A number of different studies have described the impor-
be located within specialized lipid microdomains of the tance of cyclic nucleotide levels in the neuronal re-
growth cone membrane, as membrane rafts. Such mem- sponse to myelin-derived inhibitors of axon growth (re-
brane rafts are rich in cholesterol, sphingomyelin, and viewed by Snider et al., 2002). The levels of cAMP and
gangliosides, and NgR, as a GPI-anchored protein, cGMP can alter the effects of neurotrophic and guidance
could potentially link to sphingomyelin. In addition, Rho factors, with low levels of cyclic nucleotides promoting
has been shown to associate with lipid rafts. Intriguingly, chemorepulsion, and high levels supporting chemoat-
the major brain gangliosides GD1 and GT1b had been traction. Elevation of cAMP in the growth cones can
previously suggested as candidate MAG receptors (Vin- convert repulsion by MAG to attraction. Although as yet
son et al., 2001; Vyas et al., 2002). Neurite growth is untested, it seems likely that cyclic nucleotide levels
reduced by addition of soluble GD1a and GT1b to neu- will also be found to be important in Nogo and OMgp
rons plated on MAG CHO cells (Vinson et al., 2001), and signaling.
multivalent clustering of gangliosides completely blocks The relationship between cAMP and Rho signaling to
neurite growth in the absence of inhibitory molecules overcome growth inhibition has not been well studied
(Vyas et al., 2002). In addition, neurons from transgenic in neurons, but experiments in other systems have
mice engineered to lack gangliosides are not inhibited shown that protein kinase A can phosphorylate Rho,
by MAG (Vyas et al., 2002). Yamashita and colleagues preventing its activation. Phosphorylation of Rho also
causes it to dissociate from the membrane. Thus, onealso found that the ganglioside GT1b associated with
Neuron
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possibility is that increased levels of cAMP may disrupt ress made in this field gives real hope for therapeutic
interventions to promote repair after spinal cord injury.the NgR signaling complex, and as a consequence, Rho
is no longer able transmit inhibitory signals. Further work Conclusion
Our new understanding of MAG, Nogo, and OMgp aswill be required to test this model.
Convergent Progress in Spinal Cord myelin-derived growth inhibitory proteins provides a ba-
sis for studies of growth inhibitory signaling in the CNS.Injury Research
In the last several years, exciting progress has been These new findings indicate that myelin-derived growth
inhibitory proteins are not only important for regenera-made in elucidating new ways to stimulate regeneration.
Many of the proposed strategies either block inhibitory tion, but have an important role in regulating plasticity
and axon–glial interactions. The novel findings provideproteins or block signaling by inhibitory proteins. Alter-
ing the inhibitory environment of the CNS with antibod- new avenues to explore the neuronal response to growth
inhibitory molecules and lead to further understanding ofies raised against inhibitory proteins has been tested
in many different injury models. For instance, the IN-1 the barriers to axon regeneration after injury in the CNS.
antibody promotes axon regeneration on myelin in many
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